[General characteristics and clinical importance of the new beta-adrenomimetic, Pre-par, in obstetrics and gynecology].
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007751:Labor, Induced; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009215:Myometrium / Q000187:drug effects / Q000294:innervation; D010120:Oxytocics; D011247:Pregnancy; D011412:Propanolamines / Q000627:therapeutic use*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D012312:Ritodrine / Q000009:adverse effects / Q000627:therapeutic use*; D014590:Uterine Contraction / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D010120:Oxytocics; D011412:Propanolamines; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D012312:Ritodrine
Obshta kharakteristika i klinichno znachenie na noviia beta-adrenomimetik Pre-par v akusherstvoto i ginekologiiata.